跳至主要内容
临床试验/DRKS00000766
DRKS00000766招募中4 期

heart rate control after acute myocardial infarction - STEMI

niversität zu Köln0 个研究点目标入组 100 人开始时间: 2011年10月6日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Acute st-segment elevation myocardial infarction (time between symptom onset and PCI < 6 hours) with successful PCI (TIMI III°)
  • Killip Klassification I, II
  • Written informed consent
  • Resting heart rate = 60 bpm
  • Age above 18 years
  • Mean blood pressure = 65 mmHg
  • Systolic blood pressure > 90mmHg
  • Medication with Heparin (weight adapted), clopidogrel ans aspirin before PCI
  • SO2 > 90%
  • Elevated heart rate (= 60/min)

排除标准

  • Mean blood pressure < 65 mmHg
  • Incomplete PCI success (TIMI < III)
  • Cardiogenic shock
  • Killip Klassification III, IV
  • Symptomatic AV conduction block II°, III°,
  • sinuatrial conduction block (II°, III°)
  • Catecholamin therapy
  • Heart rate < 60/min.
  • Severe peripheral artery disease (Fontaine > IIb)
  • Moderate to severe renal impairment (Serum-creatinin > 2 mg/100ml)
  • Severe liver dysfunction
  • Severe acidosis (pH < 7,2)
  • Known contraindications for Brevibloc (e.g. asthma bronchiale) or known intolerance to Brevibloc
  • Participation in other interventional studies
  • Person related to the sponsor or investigator
  • Subjects who were not eligible for follow-up visits (e.g. due to long distance between study hospital and home adress)
  • Women in whom a pregnancy cannot excluded
  • Missing safe contraception (hormonal or copper spirale)
  • Patients without guidelines recommended therapy previosly to PCI
  • Patients in whom anamnestic the symptom onset was > 6 hours or first laboratory tests indicate (LDH > 280U/I) that the myocardial infarction onset was more than 6 hours and in whom no other reasons for elevated LDH are present.
  • Unsuccessful PCI
  • Symptom onset > 6 hours

研究者

发起方
niversität zu Köln

相似试验